These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30709683)

  • 1. A letter of reply to the commentary by Dr. Stamp et al.
    Ichida K
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):111-112. PubMed ID: 30709683
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment.
    Knake C; Stamp L; Bahn A
    Biochem Biophys Res Commun; 2014 Sep; 452(1):157-62. PubMed ID: 25152400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapy.
    Keith MP; Gilliland WR
    Clin Pharmacol Ther; 2011 Sep; 90(3):363-4. PubMed ID: 21862966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Rheumatology (Oxford); 2012 Sep; 51(9):1670-6. PubMed ID: 22539486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxipurinol: alloxanthine, Oxyprim, oxypurinol.
    Drugs R D; 2004; 5(3):171-5. PubMed ID: 15139781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wastewater-based estimation of the prevalence of gout in Australia.
    Ahmed F; Tscharke B; O'Brien J; Thompson J; Samanipour S; Choi P; Li J; Mueller JF; Thomas K
    Sci Total Environ; 2020 May; 715():136925. PubMed ID: 32007890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.
    Stamp LK; Wallace M; Roberts RL; Frampton C; Miner JN; Merriman TR; Dalbeth N
    Drug Metab Pharmacokinet; 2018 Dec; 33(6):241-242. PubMed ID: 30274827
    [No Abstract]   [Full Text] [Related]  

  • 11. A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis.
    Wright DF; Doogue MP; Barclay ML; Chapman PT; Cross NB; Irvine JH; Stamp LK
    Eur J Clin Pharmacol; 2017 Jan; 73(1):71-78. PubMed ID: 27683090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of a therapeutic drug monitoring service for allopurinol therapy.
    Kannangara DR; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO
    Ther Drug Monit; 2013 Dec; 35(6):863-6. PubMed ID: 24263644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry.
    Stocker SL; Franklin ME; Anderson JM; Pillans PI; Williams KM; McLachlan AJ; Day RO; Taylor PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2363-8. PubMed ID: 20702150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of allopurinol and oxypurinol in human plasma and urine by liquid chromatography-tandem mass spectrometry.
    Liu X; Ni XJ; Shang DW; Zhang M; Hu JQ; Qiu C; Luo FT; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():10-6. PubMed ID: 24184830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma oxypurinol as a measure of adherence in clinical trials.
    Stamp LK; Merriman T; Frampton C; Zhang M; Wallace M; Miner JN; Dalbeth N
    Ann Rheum Dis; 2018 Feb; 77(2):313-314. PubMed ID: 28057666
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.
    Day RO; Graham GG; Hicks M; McLachlan AJ; Stocker SL; Williams KM
    Clin Pharmacokinet; 2007; 46(8):623-44. PubMed ID: 17655371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
    Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
    Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.